Altech Batteries (ATC:AU) has announced Altech – CERENERGY Project Secures German Grant Approval
Download the PDF here.
Altech Batteries (ATC:AU) has announced Altech – CERENERGY Project Secures German Grant Approval
Download the PDF here.
Centurion Minerals offers investors an early-stage entry point into a strategically located gold exploration company positioned within one of North America’s most prolific and active mining districts. With a restructured corporate foundation, and a highly experienced geological and corporate finance team, the company is primed for value-creating discoveries.
Centurion Minerals (TSXV:CTN) is a Canadian exploration company focused on the acquisition, exploration and development of precious metals projects in the Americas.
The company’s strategy is centered on advancing high-quality, early-stage gold assets through systematic exploration to define drill-ready targets and unlock the discovery potential inherent in its three-part claim package: the Newman, Noseworthy and Hepburn properties. Situated near major operations and new discoveries, these claims benefit from excellent infrastructure, year-round road access and proximity to proven mineralized structural corridors. Centurion intends to increase shareholder value through targeted geophysics, ground truthing and drilling programs designed to reveal new high-grade zones, as well as through potential future acquisitions of complementary gold assets across the Americas.
Backed by a leadership team with decades of exploration, geology, corporate finance and project development experience, Centurion is positioned to capitalize on strong gold market fundamentals and renewed investor interest in junior exploration companies. With a low current valuation and advancing work program, the company provides leverage to both exploration success and broader trends in the gold sector.
The Casa Berardi West project is Centurion’s flagship gold exploration asset, encompassing approximately 6,732 hectares across three contiguous claim groups – Newman, Noseworthy and Hepburn – located 66 km northeast of Cochrane, Ontario. The project sits along structural corridors that host some of the region’s most significant deposits, including Hecla Mining’s Casa Berardi mine (3 Moz past production, plus 4 Moz in reserves and resources), Agnico Eagle’s Detour Lake mine (15 Moz reserve, producing ~659,000 oz of gold per year ), and AMEX Exploration’s Perron discovery (1.6 Moz measured and indicated resource at 6.14 g/t gold).
Location of the three claim groups at Casa Berardi West
The project is situated within the central north Abitibi Subprovince, an Archean greenstone belt known globally for its prolific endowment of gold and base metals. The claims lie adjacent to geological features associated with multiple major deposits – iron formations, shear zones and VMS trends – creating strong analogues to high-grade gold mines such as the Musselwhite mine in Northern Ontario.
This “closeology” positioning significantly enhances the potential for Centurion’s ground to host similar mineralization.
Historic exploration across the Casa Berardi West project – spanning more than 70 RC and diamond drill holes – has already confirmed the presence of gold-bearing structures and favorable host rocks. Notably, previous work returned multiple samples above 1 g/t gold, including a standout result of 38 g/t gold, demonstrating strong mineralization potential across the claim area.
Significant historic drill results at Newman target
Across the three claim groups, drilling and geophysical surveys have identified key geological features associated with major deposits in the region, including iron formations, shear zones and sulphidized horizons. Several zones of interest remain untested or underexplored, particularly along structural trends that extend from nearby high-grade gold and VMS systems such as the Perron and Normetal areas.
These findings provide Centurion with multiple high-priority target areas for follow-up exploration, forming the foundation for its next phase of geophysical work and upcoming drill targeting.
David Tafel brings over 30 years of experience in corporate structuring, strategic planning, financing and executive management across multiple public and private resource companies. He has raised several hundred million dollars for ventures in mining, technology and life sciences, and previously managed private investment funds at Canada’s largest independent securities firm.
A seasoned financial executive with more than 20 years of experience, Jeremy Wright serves as president & CEO of Seatrend Strategy Group and has held CFO roles across numerous public companies in the resource and technology sectors. His background includes financial management, negotiations and environmental economics, supported by extensive board leadership experience.
Joseph Del Campo has served as CFO and Interim CEO across several mining companies, including Unigold and First Nickel. With decades of corporate financial leadership and board experience, he contributes deep governance, audit and operational oversight expertise to Centurion’s board.
A veteran geologist with 40+ years of industry experience, Mike Kilbourne has managed over 100,000 metres of drilling across North America and Mexico, worked as a production geologist in multiple mining environments, and generated over 700 exploration targets for private and public companies.
Jamie Lavigne is a senior exploration geologist with more than 30 years of experience in base and precious metals. He has held senior technical roles with major mining companies and specializes in advanced exploration, resource delineation and geological modeling across global mineral belts.
Here’s a quick recap of the crypto landscape for Monday (January 5) as of 9:00 p.m. UTC.
Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrency market news.
Bitcoin (BTC) was priced at US$94,127.01, up by 3.2 percent over 24 hours.
Bitcoin price performance, January 6, 2025.
Chart via TradingView.
Bitcoin started Monday strong, rising above US$92,000 in early trading before briefly breaking US$94,600, signaling a potential shift in near-term momentum after a bruising finish to 2025.
Research firm 10X said the move reflects a return to more normalized trading volumes and early signs of renewed institutional positioning at the start of the year. The firm notes that Bitcoin is holding above key moving averages, with the 21 day line emerging as a critical support level for maintaining upside bias.
It added that the shift suggests growing expectations for a push toward the US$100,000 level. The rebound follows three consecutive monthly declines — a historically rare pattern that has often preceded January recoveries.
“The strength across crypto and traditional safe havens reflects a rebalancing phase driven by geopolitical risk and liquidity positioning,” said Lacie Zhang, a research analyst at Bitget Wallet.
“In this setup, Bitcoin has room to push toward US$105,000, while Ethereum could test US$3,600, as traders balance inflation risks with crypto’s deflationary characteristics and long-term adoption narrative.’
Zhang said DeFi is currently driving significant growth, with protocols such as Uniswap (UNI) and Aave (AAVE) seeing benefits from improved governance, new revenue-sharing frameworks and institutional investor involvement.
“For large-cap altcoins, XRP and Solana stand out: XRP’s role in cross-border payments and improving regulatory clarity, combined with ETF inflows, could support price ranges of US$5 – US$10, while Solana’s high-throughput ecosystem and network expansion position it for US$500 – US$800 over the next growth phase.
“The renewed surge in memecoin activity reflects improving retail risk appetite,” she added. “It’s not a long-term thesis, but often a precursor to liquidity rotating into higher-quality, utility-driven altcoins as the cycle matures.”
Ether (ETH) was priced at US$3,239.82, up by 3.2 percent over the last 24 hours.
Global crypto exchange-traded products attracted US$47.2 billion in net inflows in 2025, falling just short of the prior year’s record despite a noticeable slowdown in Bitcoin demand, according to CoinShares.
Bitcoin-focused products added US$26.9 billion, a sharp drop from 2024 levels, as price weakness dampened inflows and modest interest emerged in short-bitcoin vehicles. The cooling in Bitcoin was offset by a surge into select altcoins, led by Ethereum products, which posted US$12.7 billion in inflows.
Meanwhile, XRP and Solana funds followed closely as each recorded multibillion-dollar inflows and triple-digit percentage growth year over year.
Satsuki Katayama, Japan’s finance minister, has signaled stronger government backing for integrating digital assets into the country’s stock and commodities exchanges.
Speaking at the Tokyo Stock Exchange, she emphasized the role of exchanges in expanding public access to blockchain-based assets and modern investment tools. She pointed to the US experience with crypto-linked exchange-traded funds (ETFs) as a reference point, even as Japan currently lacks domestically listed crypto ETFs.
Katayama described 2026 as a “digital year,” pledging policy support for exchanges adopting advanced trading technologies. The remarks build on regulatory reforms already underway, including discussions on allowing banks to hold crypto assets and the approval of Japan’s first yen-pegged stablecoin.
Bitget’s new Universal Exchange vision has reached two major milestones that signal a major shift in how digital and traditional assets are traded in one place. Bitget announced last week that its tokenized stock volume surpassed US$1 billion, with 95 percent of that total volume occurring in December alone.
Building on that momentum, and following a successful private beta with over 80,000 users, today Bitget officially opened its TradFi trading suite to the public, allowing customers access to 79 different instruments across forex, metals, indices and commodities. These products are traded as contracts for difference and are settled entirely in USDT, meaning crypto-native traders can execute macro strategies without leaving the platform or converting to fiat currency.
During the test phase, XAU/USD recorded over US$100 million in single-day trading volume, one of the highest daily figures observed during the beta.
“Traders want the flexibility to choose between assets in a unified ecosystem,” said Chen.
“They want the freedom to move between crypto and traditional markets as conditions change. TradFi going public is about giving them that accessibility in one place, without friction.”
The move signals a broader shift in how exchanges are evolving, not just as venues for speculation, but as comprehensive gateways to global markets under a unified trading experience.
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
From established players to up-and-coming firms, Canada’s pharmaceutical landscape is diverse and dynamic.
Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are playing a role in the landscape as well.
Read on to learn about what’s been driving the share prices of the best-performing Canadian pharma stocks.
Year-on-year gain: 26.6 percent
Market cap: C$149.8 million
Share price: C$4.76
HLS Therapeutics focuses on drugs for cardiovascular and central nervous system problems, often through partnerships. The company specializes in acquiring and commercializing pharmaceuticals that address unmet needs, including Vascepa to reduce cardiovascular risk and Clozaril for treatment-resistant schizophrenia.
HLS in-licensed the exclusive rights to the treatments Nilemdo and Nexlizet, both of which are already approved in other countries, from Esperion (NASDAQ:ESPR) in May.
The November 2025 Health Canada approval of LDL-cholesterol lowering treatment Nilemdo represents the most significant catalyst for the company since the launch of Vascepa, positioning HLS as a dominant leader in the Canadian cardiovascular market. The company is targeting Nilemdo’s commercial launch in Q2 2026.
Along with the approval, Health Canada issued a notice of non-compliance for its Nexlizet cholesterol-reducing treatment. According to HLS, the decision was related to chemistry, manufacture and controls data, not clinical data or safety.
Additionally, the company generates revenue from a diversified portfolio of royalty interests on various products marketed by third parties.
Year-on-year gain: 14.49 percent
Market cap: C$141.04 million
Share price: C$0.79
Satellos Bioscience is a Canadian pharmaceutical company expanding treatment options for muscle disorders. The company has focused specifically on Duchenne muscular dystrophy, developing therapies that target the specific biological pathways involved in regenerating and repairing muscle tissue.
Its lead candidate, SAT-3247, targets a protein called AAK1, which regulates the activity of stem cells that activate and differentiate new muscle fibers.
In Q4 2025, Satellos administered the first dose to a patient in its 11-month open-label follow-up study for adults who completed its initial Phase 1b trial. The study seeks to demonstrate the lasting impact of the significant functional improvements observed earlier in the year.
On December 9, the company received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) and several other global regulators to initiate BASECAMP, a global Phase 2 randomized, placebo-controlled study to evaluate SAT-3247 in pediatric patients.
Year-on-year gain: 14.29 percent
Market cap: C$592.59 million
Share price: C$6.00
Knight Therapeutics is a specialty pharmaceutical company headquartered in Montreal, Québec. It operates on an acquisition and in-licensing model, obtaining the rights to innovative medicines from global pharmaceutical companies and commercializing them across Canada and Latin America.
The company was originally founded by the former leaders of Paladin Labs, which was acquired by Endo International in 2014. In June 2025, Knight bought the Paladin business back from Endo for C$107 million, adding over 40 products to Knight’s Canadian roster.
The additions, helped drive 32 percent revenue growth year-over-year to a record C$122.55 million in Q3. The company projects its Knight Canada subsidiary will be the company’s top revenue-contributor within two years.
Year-on-year gain: 10.07 percent
Market cap: C$146.89 million
Share price: C$12.90
BioSyent is a specialty pharmaceutical company focused on in-licensing or acquiring established, high-margin healthcare products for the Canadian and international markets. Its growth is anchored by brands in iron health and women’s wellness. Its flagship brand, FeraMAX, has been Canada’s leading iron supplement for over a decade.
The company’s 2024 acquisition of Tibella, a treatment for menopausal symptoms, has been a major growth driver. According to its Q3 earnings report. BioSyent’s sales grew 19 percent year-over-year in Canada and 94 percent in the international market.
Year-on-year gain: 6.45 percent
Market cap: C$47.54 million
Share price: C$0.66
NurExone Biologic is behind ExoTherapy, a drug-delivery platform that uses exosomes, which are nano-sized extracellular vesicles, to create treatments for central nervous system disorders, spinal cord injuries and traumatic brain injuries. It is a less invasive alternative to cell transplantation, which requires surgery and carries the risk of rejection.
NurExone’s first nano-drug, ExoPTEN, uses a proprietary sIRNA sequence delivered with the ExoTherapy platform to treat spinal cord injuries. ExoPTEN received orphan drug designation from the US FDA in October 2023.
The company expects to initiate its Phase 1/2a first-in-human trial for acute spinal cord injury in the second half of 2026, targeting patients with traumatic injuries.
It continues to make significant progress, with recent preclinical studies demonstrating strong, dose-dependent vision recovery in glaucoma models and improved motor function in spinal cord injury models.
The company announced plans for a US exosome production facility in Indianapolis, Indiana, in September. According to the release, ‘The GMP compliant site would produce exosomes both for NurExone’s therapeutic pipeline and for a growing business-to-business opportunity in regenerative aesthetics.’
In December, the company began planning for small-scale production of ExoPTEN in Israel to support its clinical trial.
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
NCAA women’s hockey returned in full force following the holiday break.
Dozens of games were on the schedule, including Minnesota-Duluth, Harvard, Quinnipiac and Boston University facing off in Belfast, Northern Ireland, as part of the Friendship Series.
Teams are in their final stretch before many of the top players in NCAA women’s hockey travel to Italy for the 2026 Olympics, a departure that will significantly affect some of the top programs in the nation. With that change coming, teams wasted no time fighting for positioning in the standings as they returned to action.
Here’s a look at the top 10 NCAA women’s hockey programs this week:
The powerhouse program didn’t play, but it did see Laila Edwards, Kirsten Simms, Caroline Harvey and Ava McNaughton named to USA’s Olympic women’s hockey team. They will face Minnesota-Duluth, which is coming off a pair of disappointing losses in Europe this week, which should tip the scales further in Wisconsin’s favor. Until someone proves otherwise, the Badgers look like the team to beat.
Ohio State swept the top team from Atlantic Hockey America, Penn State, handing the Nittany Lions their second and third losses of the season. Ohio State showed the WCHA’s dominance, outshooting No. 4 Penn State 85-45 in the two-game series, earning 4-1 and 5-1 wins. Senior Sloane Matthews, who will enter the 2026 PWHL Draft, led the way offensively with two goals and four points.
Minnesota had a walk in the park facing Sacred Heart. They set a program record, scoring 14 goals in the second game of their series and outscoring the NEWHA program 18-2. The series allowed American national team member Abbey Murphy to catapult into the national scoring lead as she recorded nine points in Minnesota’s lopsided wins.
Penn State failed to hold their ground against Ohio State but also weren’t completely outplayed in their series loss despite being outscored 9-2 across two games. Tessa Janecke and Maddy Christian, in particular, were threats for Penn State. The Nittany Lions vastly improved in the second game, a 4-1 loss to Ohio State. If it were not for a trio of power-play goals by the Buckeyes, things could have been different.
Playing in Northern Ireland, Quinnipiac skated to a 2-2 tie against Boston University, before a shootout sent BU to the final and the Bobcats to a third-place matchup against Minnesota-Duluth. In the third-place game, the Bobcats responded by upsetting Minnesota-Duluth. Quinnipiac was backed by strong netminding from Felicia Frank and the offensive play of Kahlen Lamarche, who sits second in the nation in goals with 23.
Minnesota-Duluth struggled to find their way through the jet lag of travelling to Belfast for the Friendship Series. They fell in overtime to unranked Harvard, then dropped a 3-1 decision to Quinnipiac. Scoring has remained an issue for the Bulldogs this season as they’ve recorded only 58 goals, tied for 14th in the nation.
Northeastern didn’t play, but they’ll face Yale in an upcoming midweek game and have the historic Beanpot approaching. Captain Lily Shannon is having a season to remember, vaulting herself up the PWHL draft charts, while young stars including Stryker Zablocki, Lisa Jonsson, Alessia Baechler, Eloise Caron and Morgan Jackson continue to show that Northeastern is a program that will continue to improve this season and into the future.
Cornell’s lone game following the holiday break was a tightly contested 1-0 loss to Penn State. Cornell outshot Penn State 35-32 in the loss, but couldn’t solve Katie DeSa in net. It wasn’t until Lindzi Avar took a five-minute major for hitting from behind late in the game that Penn State capitalized on the power play with only 4:24 remaining to decide the game.
Princeton had an easy weekend, outscoring Stonehill 18-1 in a pair of wins. More important than the wins was the chance for Princeton’s top players to gain confidence heading into the final stretch. Issy Wunder had five goals and nine points in the series, while Mackenzie Alexander had five goals and eight points.
UConn easily handled Providence, sweeping their weekend series. Tia Chan was spectacular in net, stopping 62 of 63 shots, including a 31-save 5-0 shutout to conclude the series. UConn has been waiting for the duo of Claire Murdoch and Julia Pellerin to heat up this season, and they showed positive signs this weekend, with Murdoch scoring in both games and Pellerin recording a goal and three assists.
The NFL playoffs are officially here. The roadmap to Santa Clara is set.
In the NFC, all things go through Seattle with the Seahawks as the No. 1 seed in the conference. The Seahawks earned the No. 1 seed for the first time since 2014. While in the AFC, the Denver Broncos clinched the top seed in the conference for the first time since 2015 season.
The Seahawks and Broncos have much-deserved byes during the wild-card round.
Wild-card weekend kicks off in North Carolina with the Los Angeles Rams vs. Carolina Panthers. Saturday night features an NFC North matchup between the Green Bay Packers and Chicago Bears.
Sunday begins with the Buffalo Bills vs. Jacksonville Jaguars. Then the defending Super Bowl champion Philadelphia Eagles play host to the San Francisco 49ers. The main event Sunday night will be the Los Angeles Chargers vs. the New England Patriots.
Wild card weekend ends when the Houston Texans pay a visit to Pittsburgh to take on the Steelers for a ‘Monday Night Football’ tilt.
USA TODAY Sports provides the early predictions for the wild-card round:
Date: Saturday, Jan. 10
Time: 4:30 p.m. ET
Location: Bank of America Stadium, Charlotte, NC
TV: FOX
Streaming: FUBO
Spread: Rams (-10)
Tyler Dragon, USA TODAY: Rams 27, Panthers 20
Carolina beat the Rams at home in Week 13 in what was probably the worst game of Matthew Stafford’s MVP-caliber season. The Rams committed three turnovers in the loss in which hardly anything went their way. I predict the Rams take better care of the football and send the Panthers packing this time. Los Angeles is the more talented team. However, the Panthers have a lot of bulletin-board material because they are a big home underdog.
Date: Saturday, Jan. 10
Time: 8 p.m. ET
Location: Soldier Field, Chicago
TV: N/A
Streaming: Prime Video
Spread: Bears (-1)
Tyler Dragon, USA TODAY: Packers 27, Bears 24
These two NFC North rivals split the season series, each winning on their home turf. The season-ending injury to Micah Parsons lowers Green Bay’s ceiling. But Jordan Love, Josh Jacobs and the Packers have a lot of firepower on offense. This will mark Chicago’s first playoff game since 2020. It’ll also be the biggest game of Caleb Williams’ young career. Will Williams rise to the moment? I think Williams plays well but the Bears falter against Green Bay.
Date: Sunday, Jan. 11
Time: 1 p.m. ET
Location: EverBank Stadium, Jacksonville, FL
TV: CBS
Streaming: FUBO
Spread: Bills (-1.5)
Tyler Dragon, USA TODAY: Jaguars 26, Bills 22
The Jaguars enter the postseason on an eight-game winning streak, the second longest active winning streak in the NFL. Coach of the year candidate Liam Coen has Trevor Lawrence playing the best football of his career. The Bills are too dependent on Josh Allen. I think Buffalo’s reliance on Allen comes back to bite the Bills.
Date: Sunday, Jan. 11
Time: 4:30 p.m. ET
Location: Lincoln Financial Field, Philadelphia
TV: FOX
Streaming: FUBO
Spread: Eagles (-3.5)
Tyler Dragon, USA TODAY: Eagles 25, 49ers 20
The 49ers have been ravaged by injuries all season. Fred Warner and Nick Bosa suffered season-ending injuries. Brandon Aiyuk didn’t even play this year. It’s a testament to Kyle Shanahan that the 49ers are even in the playoffs. This version of the 49ers can’t beat the Eagles, even if Philly doesn’t play its best brand of football. The defending Super Bowl champs are the most dangerous team in the playoffs.
Date: Sunday, Jan. 11
Time: 8 p.m. ET
Location: Gillette Stadium, Foxborough, MA
TV: NBC
Streaming: Peacock
Spread: Patriots (-3.5)
Tyler Dragon, USA TODAY: Chargers 23, Patriots 22
Justin Herbert’s never won a playoff game. Drake Maye’s never played in a playoff game. The Chargers have the NFL’s worst pass block win rate and rank second to last in run block win rate. However, the Patriots don’t have a formidable pass rush. Herbert and the Chargers pull off the biggest upset of wild-card weekend.
Date: Monday, Jan. 12
Time: 8:15 p.m. ET
Location: Acrisure Stadium, Pittsburgh
TV: ESPN
Streaming: FUBO
Spread: Texans (-3.5)
Tyler Dragon, USA TODAY: Texans 24, Steelers 19
Tyler Loop’s 44-yard shanked field goal saved Pittsburgh’s season. The Steelers will welcome back DK Metcalf, who they’ve sorely missed. However, the Texans have the NFL’s top defense. Will Anderson Jr. and Danielle Hunter have combined for 27 sacks. Derek Stingley Jr. and Kamari Lassiter each matchup well against Metcalf. The Texans should win as long as C.J. Stroud manages the game and takes care of the football.
Follow USA TODAY Sports’ Tyler Dragon on X @TheTylerDragon.
MILWAUKEE, WI —The U.S. Speedskating team is complete.
Sarah Warren, who narrowly missed the Olympic team four years ago, secured her spot at the Milano Cortina Games by winning the 500-meter race on Monday night. She was one of four skaters added to the U.S. team in the final day of the Olympic trials.
Zach Stoppelmoor qualified in the 500 meters; Ethan Cepuran got a spot in the mass start; and Giorgia Birkdale was nominated as a team pursuit specialist. They join:
Stolz will be a gold-medal favorite in all of his events, while the men’s team pursuit also will be favorites for gold. Jackson and Bowe will be contenders at both of their distances, while Mia Manganello has a chance to medal in the mass start. The women’s team pursuit also has medal potential.
‘I think it’s really good,’ Stolz said when asked to assess the team. ‘I think we have some good (medal) opportunities.’
Warren earning her spot was one of the more emotional moments of the night.
After playing soccer at the University of Illinois, Warren returned to speed skating in 2021. She nearly made the U.S. team for the 2022 Olympics in Beijing, finishing fourth in the 500 meters and fifth in both the 1,000 and 1,500 meters.
She’s had nine knee surgeries over the course of her career, and another on her ankle.
Jackson, the reigning Olympic champion in the 500 meters, had pre-qualified her spot through her success in the World Cups this season. The person with the next-fastest time after a 500-meter race Sunday and another Monday would join her.
Warren was second to Jackson on Sunday. With Jackson not racing Monday, Warren posted the fastest time to clinch her Olympic spot. When she crossed the finish line, Warren screamed and began crying.
The 2026 Milano Cortina Winter Olympics are coming! Sign up for our Chasing Gold newsletter.
The New Year is bringing some parity to the NBA.
No team is flashing the dominance that we had seen over recent stretches, as the longest active winning streak going in the league is just three games, currently held by the Boston Celtics and Philadelphia 76ers.
It’s interesting because the Celtics suddenly are creeping up the standings and are making a case for the second spot in the East – and with star player Jayson Tatum yet to play a game and possibly out all season. All of this begs the question: if Boston remains competitive deep into the season, and if Tatum is eventually cleared to return, how should the Celtics handle that?
Here are USA TODAY Sports’ NBA power rankings after Week 10 of the 2025-26 regular season:
Note: Records and stats through Jan. 4. Parentheses show movement from last week’s rankings.
1. Oklahoma City Thunder, 30-6 (+1)
2. Detroit Pistons, 26-9 (+1)
3. San Antonio Spurs, 25-10 (-2)
4. Boston Celtics, 22-12 (+2)
5. Denver Nuggets, 23-12 (—)
6. New York Knicks, 23-12 (-2)
7. Minnesota Timberwolves, 23-13 (—)
8. Los Angeles Lakers, 22-11 (+1)
9. Houston Rockets, 21-11 (-1)
10. Phoenix Suns, 21-14 (—)
After prying away the top spot from the Thunder last week, the Spurs have lost three of their last five as Victor Wembanyama suffered another injury scare. So, even though the Thunder have been vulnerable, and even though they have struggled against teams with defensive length and athleticism at the wing, OKC regains No. 1 status.
The Celtics, though, have been quiet risers behind Jaylen Brown, who is having an MVP-caliber season without Jayson Tatum (Achilles); Boston suddenly has the NBA’s second-ranked offensive rating. The Lakers are seemingly dealing with internal tension amid lingering questions about their subpar defense and offensive fit issues with Luka Dončić and LeBron James, but L.A. keeps on winning.
11. Toronto Raptors, 21-15 (+1)
12. Philadelphia 76ers, 19-14 (+3)
13. Miami Heat, 20-16 (—)
14. Orlando Magic, 20-16 (-3)
15. Cleveland Cavaliers, 20-17 (-1)
16. Golden State Warriors, 19-17 (—)
17. Chicago Bulls, 17-18 (+1)
18. Milwaukee Bucks, 16-20 (+1)
19. Portland Trail Blazers, 16-20 (+2)
20. Atlanta Hawks, 15-18 (-5)
Joel Embiid is playing more minutes for the Sixers and is averaging 28.7 points per game over his last seven. The Heat, after losing nine of 11 throughout December, have course corrected and have returned to their offensive pace with Norman Powell making an All-Star push. Miami has won five of its last six, including one against the top seed in the East, the Pistons.
The Magic have to figure out how to incorporate Paolo Banchero into the offense more efficiently, as his on-off numbers remain relatively underwhelming. And the Hawks are simply out of sorts – whether Trae Young is on the floor or not – losing 12 of their last 16 games.
21. Los Angeles Clippers, 12-22 (+2)
22. Memphis Grizzlies, 15-20 (-5)
23. Dallas Mavericks, 13-23 (+1)
24. Utah Jazz, 12-22 (-2)
25. Charlotte Hornets, 12-23 (—)
26. Brooklyn Nets, 11-22 (—)
27. Washington Wizards, 9-25 (+2)
28. New Orleans Pelicans, 8-29 (-1)
29. Sacramento Kings, 8-28 (-1)
30. Indiana Pacers, 6-30 (—)
Are the Clippers all the way back? Over their last 10 games, no team has posted a higher offensive rating than Los Angeles (123.0), and Kawhi Leonard has been on an absolute heater, averaging 36.6 points per game over his last seven. The Mavericks got Anthony Davis back and upset the Rockets on Jan. 3, but Dallas will need the big man healthy to climb into the playoff picture.
The Nets have been more competitive on defense, but that hasn’t led to consistency with victories. Winners of four of their last six, the Wizards are getting decent contributions from young starters and from Justin Champagnie and Bub Carrington off the bench.
The WNBA and WNBPA appear to be at an impasse as the deadline for new collective bargaining agreement approaches on Friday, Jan. 9.
The league has not moved off of any of the numbers from its last offer reported in December.
‘We are at a bit of standstill,’ WNBPA vice president Napheesa Collier said when asked about the CBA on ‘Good Morning America’ on Monday, Jan. 5. ‘The timeline is coming up in a couple of days. It’s gonna expire.’
Collier, who was appearing on GMA to tout the second season of Unrivaled, a 3-on-3 league she co-founded with Breanna Stewart, said no one wants a work stoppage but the players will continue to ask for what they believe they deserve.
‘We’re just excited to show at Unrivaled that it is possible to pay the players and create a successful business,’ Collier said. ‘And that’s what we hope to do in the WNBA as well.
‘We feel really confident in what we’re asking for, and I just feel really blessed to be able to play and create something that is already showing that these things are possible.’
WNBA players voted to authorize the WNBPA’s executive committee to ‘call a strike when necessary,’ in late December. The current CBA is set to expire on Jan. 9, 2026, following two extensions from the original Oct. 31 deadline.
The league has proposed a system where players would receive in excess of 70% of net revenue, a person with direct knowledge of the situation told USA TODAY Sports. The WNBA’s offer includes a maximum $1 million base salary, with a projected revenue sharing component that raises players’ max total earnings to more than $1.3 million in 2026. The maximum salary would grow to nearly $2 million over the life of the agreement. The proposal raises the minimum salary to more $250K and the average salary to more than $530K, growing to more than $780,000 over the life of the deal.
The players have prioritized increased revenue sharing and salary structures in negotiations. According to The Athletic, the league has offered revenue sharing at 15% while the union has proposed 30%. The sides also differ on how that percentage, as well as the salary cap, would be calculated.
When asked to comment on the bargaining, WNPBA executive director Terri Jackson sent this statement to USA TODAY Sports:
“The players know the difference between doing business and creating click-bait. They are focused on the system. Despite what the league and the teams are trying to do, the players are not confused by the numbers. The players want a meaningful share of the revenue they are creating. They want to be properly valued in these negotiations and this next CBA. They do not want to be paid last with only a fraction of the dollars left over.
‘I cannot comment on the specifics of any proposal but I can speak hypothetically. The players would not have opted out of the 2020 CBA with a fixed salary system giving them less than 10% of the revenue that their labor drives only to agree to a salary system that is arguably tied to revenue but now gives them less than 15%. The business has grown considerably and the league and the teams project incredible sustainable growth into the (foreseeable) future.
‘How do the capital investors, Changemakers, any one who cares about women’s sports, supports women athletes, understands the value of this investment believe this could be a good deal? Again, hypothetically speaking.”
Asara Resources (AS1:AU) has announced Ongoing drilling continues to return broad gold intercepts
Download the PDF here.